The Homeiku Foundation, Which Provides the “Praise and Raise” Educational Method to More Than 500,000 People in 18 Countries Around the World, Published Their Book in Spain, Kickstarting Mutual Praise Service Between Countries
10.5.2022 12:41:00 EEST | Business Wire | Press release
The Homeiku {Ho-May-E-ku} Foundation has published its first book (titled "El libro de las alabanzas") in Spain. The foundation has provided the Homeiku method of nurturing people through praise to more than 500,000 people in 18 countries around the world. With the publication of the book in Spain and the launch of their services overseas, the foundation aims to further spread their mission of "making people in 196 countries shine through the Homeiku method."
Homeiku is an abbreviation for "Praise Education", which is a Japanese educational method that has been perfected through the combined studies of brain science and psychology along with the educational experience that Mr. Hara has cultivated over the years. This intrinsic method aims to support mental development by educating each individual to maximize their abilities through the power of “praise words”, with the ultimate goal for one to achieve self-fulfillment.
More than 400 companies have implemented Homeiku in their businesses, and the recognition of Homeiku's success around the world has led to the publication of the book in Spain. The content, which was published in Japan in December 2016 and has been a huge hit with 36,000 copies in 12 printings, has been translated into Spanish and localized for European culture.
The book consists of four sections: 1) The Amazing Power of Praise, 2) Praise that Reaches Others and Praise that Doesn't, 3) The 12 Rules for Becoming a Good Complimenter, and 4) How to Live a Life of Happiness through Praise. The book is designed to help couples, parents and children, friends, and colleagues improve their relationships with each other, and people who receive encouragement grow and create a cycle of happiness in their lives.
About the Homeiku Foundation:
The Homeiku Foundation was founded by Mr. Kunio Hara, who has since introduced his Praise method to more than 400 companies worldwide. Mr. Hara appeared twice at TEDx, authored 20 books (translated into English, Spanish, Chinese, and Korean), and is also a special advisor for the Council for the Promotion of National Education.
TEDx Videos:
https://www.youtube.com/watch?v=-oimrd7K59Q
https://www.youtube.com/watch?v=y5_vcu5fPAk
Publication URL:
https://www.esferalibros.com/libros/el-libro-de-las-alabanzas/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005436/en/
Contact information
Inquiries:
General Incorporated Association: Homeiku Foundation
Kaoru Sasazaki
info@spiral-up.jp
+81-6-6281-1226
https://homeiku.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S
European Commission Approves DAYBU ® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 10:01:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 09:36:00 EEST | Press release
Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi
Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 09:03:00 EEST | Press release
Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial network that connects banks, telcos, payment and liquidity providers to enable settlement across international markets. Fasset will also increase investment in agentic AI-enabled systems supporting corridor banking, stablecoin settlement and tokenized asset infrastructure. After raising Series B in May, Fasset has now raised a total of $119 million in 2026. The financing marks Fasset’s entry into the glob
Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 08:11:00 EEST | Press release
Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom